Predicting clinical trial duration via statistical and machine learning models.

ABSTRACT: We apply survival analysis as well as machine learning models to predict the duration of clinical trials using the largest dataset so far constructed in this domain. Neural network-based DeepSurv yields the most accurate predictions and we identify key factors that are most predictive of trial duration. This methodology may help clinical researchers optimize trial designs for expedited testing, and can also reduce the financial risk of drug development, which in turn will lower the cost of funding and increase the amount of capital allocated to this sector.

SUBMITTER: Cho J 

PROVIDER: S-EPMC12005917 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature